Dr CiptoMangunkusumo National General Hospital CMNGH, Jakarta
Child and Adolescent Health Dept
Hearing loss is one of the most common congenital disordersencountered in high risk neonates.The incidence is 1 – 6/1000 live births and relatively higher inhigh-risk babies.The incidence of hearing loss in Iran has been shown to be as high as 8% in high risk neonates and 16% in Neonates in Intensive Care Unit (NICU).Despite its relatively high incidence of hearing loss particularly in high-risk neonates, hearing screening program is not a common practice in Indonesia. There are only less than ten centers running this program routinely due to lack of governmental support.
TheAmerican Academy of Pediatric (AAP): EHDI Programs for Universal Newborn Hearing Screening recommends to perform hearing screening at1, 3 and 6 month of age usingOtoacoustic Emission(OAE) and Automated Auditory Brainstem Response (AABR) test. Our unit (CiptoMangunkusumo General hospital) is the oldest and the largest tertiary referral center in Indonesia. Hearing screening at our unit is performed at least one time during hospitalization using OAE and AABR. It is advisable for these infants to be re-screened at 3 months of age.
There were 724 neonates screened during 2017. Of these neonates, there were 47 (6.24%) who had abnormal result examined at 1 month of age. There were only 28 neonates available to be re-evaluated at 3 months of age with only one infant had an abnormal test. The risk factors for having abnormal hearing screening result were septicemia, aminoglycoside use, and hyperbilirubinemia requiring light therapy.